Clinical Roundup USPSTF issues draft recommendation statement on screening for cervical cancer December 13, 2024Vol.50 No.46
Clinical Roundup Lynparza demonstrates survival benefit in early breast cancer, phase III trial data show December 13, 2024Vol.50 No.46
Clinical Roundup Imlunestrant improves PFS in breast cancer, phase III data show December 13, 2024Vol.50 No.46
Clinical Roundup Phase III trial shows improved PFS in treatment of CLL using pirtobrutinib December 13, 2024Vol.50 No.46
Clinical Roundup AI test is equivalent to Oncotype DX at predicting breast cancer recurrence, study shows December 13, 2024Vol.50 No.46
Clinical Roundup MammaPrint test demonstrates utility in predicting chemotherapy benefit over five years December 13, 2024Vol.50 No.46
Clinical Roundup Genetic disposition increases the risk of breast cancer metastasis December 13, 2024Vol.50 No.46
Clinical Roundup Kisqali shows reduction in distant recurrence in early breast cancer, phase III data show December 13, 2024Vol.50 No.46
Clinical Roundup Darzalex Faspro-based regimens demonstrate improved rates of MRD negativity and PFS December 13, 2024Vol.50 No.46
